VRNA
NASDAQ
GB
Verona Pharma plc - American Depositary Shares
$106.91
+0.12 (+0.1%)
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$9.2B
ROE
-38.7%
Margin
-36.6%
D/E
87.12
Beta
-0.10
52W
$43–$107
Wall Street Consensus
18 analysts · Feb 20262
Strong Buy
4
Buy
12
Hold
0
Sell
0
Strong Sell
33.3%
Buy Rating
Price Chart
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2025 | $0.05 | $0.13 | +$0.08 |
| Mar 2025 | $-0.15 | $-0.16 | $-0.01 |
| Dec 2024 | $-0.30 | $-0.40 | $-0.10 |
| Sep 2024 | $-0.51 | $-0.56 | $-0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -38.7% | -89.8% | -38.7% | -38.7% | -38.7% | -38.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 11.6% | -78.5% | -36.6% | -36.6% | -36.6% | -36.6% |
| Gross Margin | 95.4% | 95.0% | 95.2% | 95.2% | 95.2% | 95.2% |
| D/E Ratio | 87.12 | 106.68 | 87.12 | 87.12 | 87.12 | 87.12 |
| Current Ratio | 10.71 | 8.86 | 10.71 | 10.71 | 10.71 | 10.71 |
Key Ratios
ROA (TTM)
-16.6%
P/S (TTM)
41.57
P/B
18.6
EPS (TTM)
$-0.12
CF/Share
$-0.46
Rev Growth 3Y
+1.9%
52W High
$106.93
52W Low
$43.44
$43.44
52-Week Range
$106.93
How does VRNA compare to Pharmaceuticals peers?
Peer group: Mid-cap Pharmaceuticals ($2B+) · 25 companies
VRNA valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Fair value
P/S ratio
41.6
▲
519%
above
peers
(6.7)
vs Peers
vs Industry
Overvalued
P/B ratio
18.6
▲
256%
above
peers
(5.2)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(3.1%)
vs Peers
vs Industry
Low yield
VRNA profitability vs Pharmaceuticals peers
ROE
-38.7%
▼
48%
below
peers
(-26.1%)
vs Peers
vs Industry
Weak
Net margin
-36.6%
▼
2426%
below
peers
(-1.5%)
vs Peers
vs Industry
Weak
Gross margin
95.2%
▲
7%
above
peers
(88.9%)
vs Peers
vs Industry
In line
ROA
-16.6%
▼
76%
below
peers
(-9.5%)
vs Peers
vs Industry
Below avg
VRNA financial health vs Pharmaceuticals peers
D/E ratio
87.1
▲
219%
above
peers
(27.4)
vs Peers
vs Industry
High debt
Current ratio
10.7
▲
208%
above
peers
(3.5)
vs Peers
vs Industry
Strong liquidity
Beta
-0.1
▼
117%
below
peers
(0.6)
vs Peers
vs Industry
More volatile
VRNA fundamentals radar
VRNA
Peer median
Industry
VRNA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
VRNA vs peers: key metrics
Latest News
No related news yet